Coronary revascularization after myocardial infarction can reduce risks of noncardiac surgery

Masha Livhits1, Melinda Maggard Gibbons, Christian de Virgilio

  • 1Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. mlivhits@mednet.ucla.edu

Insights

Preoperative revascularization significantly reduces reinfarction and mortality in patients with recent myocardial infarction (MI) undergoing noncardiac surgery. Coronary artery bypass graft surgery offers better outcomes than stenting, particularly for early procedures.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Health Services Research

Background:

  • General consensus suggests preoperative revascularization does not improve noncardiac surgery outcomes.
  • Evidence is lacking for high-risk patients with recent myocardial infarction (MI).

Purpose of the Study:

  • To determine if preoperative revascularization improves outcomes in patients with recent MI undergoing noncardiac surgery.

Main Methods:

  • Retrospective analysis of 16,478 patients with recent MI undergoing major noncardiac surgery (1999-2004).
  • Comparison of revascularization (PTCA, stenting, CABG) versus no revascularization.
  • Outcomes assessed: 30-day reinfarction, 30-day mortality, and 1-year mortality using logistic regression.

Main Results:

  • Revascularized patients showed a ~50% reduction in reinfarction and mortality (30-day and 1-year).
  • Coronary artery bypass graft (CABG) was associated with decreased risk (RR 0.70).
  • Stenting within 1 month showed a trend toward increased reinfarction (RR 1.36).

Conclusions:

  • Preoperative revascularization benefits patients with recent MI undergoing noncardiac surgery.
  • CABG appears superior to stenting, especially for early procedures.
  • Further prospective studies are warranted.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...